Le Lézard
Classified in: Health
Subject: SVY

Insulin Biosimilars - Global Market Outlook (2017-2023)



LONDON, Jan. 11, 2018 /PRNewswire/ -- Stratistics MRC, are pleased to announce the latest publication of Global Insulin Biosimilars market. Growing pervasiveness of type 1 diabetes and ongoing approvals by the government authorities are nurturing the market growth.



Download the full report: https://www.reportbuyer.com/product/4300260



Some of the factors such as growing population exposures, technological developments and favorable medical repayment scenario in developed countries are poised to favour the market growth. However, patent protection rights of insulin and strong vengeance from the key manufacturers are some of the restraints limiting the market.

Expansion of clinically verified insulin biosimilar will cover the road for new entrants. The approaching patent expiration of insulin drugs will unlock new opportunities for the development of biosimilars and manufacturing companies. As cost is high due to strict observance requirements, prices of biosimilar drugs are anticipated to decrease as compared to branded drugs.

North America led the insulin biosimilars market due to rising demand for insulin in the region. Europe is anticipated to account for second largest share and Asia Pacific is expected to grow at a fastest rate during the forecast period. APAC players are competing on the basis of price and have pool of patients affected by diabetes, thus fueling the market growth.

Some of the key players in this market are Wockhardt Limited, Ypsomed AG, Pfizer Inc., Mylan N.V., Boehringer Ingelheim GmbH, NOVO Nordisk A/S, Sanofi S.A., Merck & Co., Biocon Limited and Eli Lilly & Co.

Biosimilars Types Covered:
? Rapid-Acting Biosimilars
? Long-Acting Biosimilars
? Premixed Biosimilars

Disease Indications Covered:
? Type I Diabetes
? Type II Diabetes

Regions Covered:
? North America
o US
o Canada
o Mexico
? Europe
o Germany
o U.K.
o Italy
o France
o Spain
o Rest of Europe
? Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
? South America
o Argentina
o Brazil
o Chile
o Rest of South America
? Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Download the full report: https://www.reportbuyer.com/product/4300260

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: sarah@reportbuyer.com  
Tel: +1 (646) 453 6293
Website: www.reportbuyer.com  

SOURCE ReportBuyer


These press releases may also interest you

at 18:23
The 12th episode of McDonald Hopkins' bi-weekly podcast series MH Business Exchange has been released. During the episode titled "Overpayment: Managing medical records requests and avoiding payor audits," Cleveland...

at 17:33
10330698 Canada Ltd. (dba Compass Cannabis Clinic, or "the Company") is a medical cannabis consultation company with thirty nine clinics that are now open or signed and in development across Canada. Compass Cannabis Clinic announced today that they...

at 17:27
Cleveland law firm Peiffer Rosca Wolf Abdullah Carr & Kane (PRW), which is nationally recognized for its handling of a number cases involving embryo loss/related cryogenic issues, today responded to the decision of the Court of Common Pleas, Cuyahoga...

at 17:19
The PKD Foundation is excited to announce that on April 24 the U.S. Food and Drug Administration (FDA) granted approval of JYNARQUEtm (pronounced jin-AR-kew and also known as tolvaptan) to be the first treatment in the United States for adult...

at 17:10
While the #MeToo movement focused on high-powered celebrities who used their status as a platform to raise awareness about sexual abuse, what about the many workers in this country who have also suffered abuse in the workplace, but, due to their more...

at 16:57
Doctors on probation for sexually assaulting their patients and for other serious misconduct causing patient harm would be required to disclose this to their patients under SB 1448 (Hill), which passed out of the Senate Business and Professions...




News published on 11 january 2018 at 14:27 and distributed by: